Researchers are investigating whether an Alzheimer's drug can slow the spread of colorectal cancer.

The Catalan company Xenopat is investigating whether a drug developed for Alzheimer's disease can help prevent the spread of colorectal cancer. In the preclinical phase, it is studying whether inhibiting a potential Alzheimer's marker could be useful against this type of cancer.